The British Neuroscience Association (BNA) is a key player in the neuroscience sector, supporting professionals and promoting interdisciplinary collaboration. Chief Executive Dr Laura Ajram highlights the importance of bridging advanced neurological research with public understanding and the latest developments in the field.
Teva and Cephalon faced the €60.5 million antitrust fine, after both companies were found to be actively suppressing the existence of cheaper medicine.
The Oxford and AstraZeneca vaccine trial gave an accidental half-dose to 3,000 people - but this mistake is the reason the vaccine acted as 90% efficient.
Today (20 November) Pfizer and BioNTech are sending their drug for approval to the FDA, meaning that the most vulnerable Americans could get the vaccine in December.
Prof Monica Di Luca, President, European Brain Council, sheds light on brain conditions, mental and neurological alike, starting with comment on the burdens presented.
Asymptomatic older patients of COVID-19 are one of the most difficult to identify - now, researchers find that delirium could be an indicator of the virus
Leading pancreatic cancer experts Professor Matthias Löhr and Professor Monique van Leerdam of United European Gastroenterology’s (UEG) Public Affairs Committee discuss the importance of early diagnosis and the latest developments in treatment for pancreatic cancer.
New research explores the link between ethnicity and ESKD, which finds that Afro-Caribbean patients are four times more likely to undergo COVID hospitalisation.
A significant increase in online searches for "insomnia" signalled to researchers that the first COVID lockdown was hard-hitting on mental health in the US.
US and UK researchers examined ethnicity data in both countries, finding that Black and Asian people were twice as likely as white people to be infected by the virus - but why?
Cecilia Van Cauwenberghe from Frost & Sullivan’s TechVision Group, China charts how to deal with dementia during the COVID-19 pandemic, starting with a helpful global and regional overview.
Cecilia Van Cauwenberghe from Frost & Sullivan’s TechVision Group considers how the standard of healthcare for patients with diabetes is impacted by COVID-19.
